RadNet

RDNT

Market cap $5.78B

Overview Fund Activity

75.20 USD

+0.83

1.12%

At close Updated Sep 17, 4:00 PM EDT

Pre-market

After hours

76.00

+0.80

1.06%

1 day

1.12%

5 days

5.43%

1 month

13.44%

3 months

32.96%

6 months

53.41%

Year to date

7.2%

1 year

12.56%

5 years

374.75%

10 years

1,105.13%

About: RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.

Employees: 11,021

Healthcare Diagnostics & Research

0

Funds holding %

of 7,463 funds

0

Analysts bullish %

of 3 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

93% more call options, than puts

Call options by funds: $2.19M | Put options by funds: $1.13M

88% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 25

78% more repeat investments, than reductions

Existing positions increased: 153 | Existing positions reduced: 86

19% more capital invested

Capital invested by funds: $3.4B [Q1] → $4.03B (+$630M) [Q2]

7% more funds holding

Funds holding: 304 [Q1] → 324 (+20) [Q2]

2.13% more ownership

Funds ownership: 92.32% [Q1] → 94.45% (+2.13%) [Q2]

0% more funds holding in top 10

Funds holding in top 10: 5 [Q1] → 5 (+0) [Q2]

See Fund Rankings

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$75

0% upside

Avg. target

$78

4% upside

High target

$81

8% upside

3 analyst ratings

3 positive

100%

0 neutral

0%

0 negative

0%

Barclays Andrew Mok	$79	Overweight Maintained	3 Sep 2025
Truist Securities David Macdonald	$81	Buy Maintained	3 Sep 2025
Raymond James John Ransom	$75	Strong Buy Reiterated	13 Aug 2025

See Analyst Rankings

Financial journalist opinion

Based on 3 articles about RDNT published over the past 30 days

RadNet, Inc. (RDNT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

RadNet, Inc. (NASDAQ:RDNT ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 4:50 PM EDT Company Participants Howard Berger - Chairman, President & CEO Mark Stolper - Executive VP & CFO Greg Sorensen Conference Call Participants Christopher Brustuen - Morgan Stanley Presentation Christopher Brustuen Managing Director Thank you all for joining us. I'm going to read the disclosure before we begin.

RadNet, Inc. (RDNT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

RadNet, Inc. to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9th, 2025

LOS ANGELES, Sept. 08, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Dr. Howard Berger, President and Chief Executive Officer, Mark Stolper, Executive Vice President and Chief Financial Officer, and Mital Patel, Executive Vice President of Financial Planning & Analysis and Chief Administrative Officer, will be presenting at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9th, 2025 at 04:50 p.m. Eastern Time.

RadNet, Inc. to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9th, 2025

Coulda, Woulda, Shoulda: Are These 5 Stocks Too Overvalued to Buy Now?

Investors worried about missing the boat on overvalued stocks need not fret. These five names, while expensive, are still seeing lots of love from analysts.

Coulda, Woulda, Shoulda: Are These 5 Stocks Too Overvalued to Buy Now?

RadNet, Inc. (RDNT) Q2 2025 Earnings Call Transcript

RadNet, Inc. (NASDAQ:RDNT ) Q2 2025 Earnings Conference Call August 11, 2025 10:30 AM ET Company Participants Howard G. Berger - Chairman, President & CEO Mark D.

RadNet, Inc. (RDNT) Q2 2025 Earnings Call Transcript

Zacks Investment Research

RadNet (RDNT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for RadNet (RDNT) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

RadNet (RDNT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges

LOS ANGELES, Aug. 10, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 405 owned and operated outpatient imaging centers, today reported financial results for its second quarter of 2025.

RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges

Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts

Insmed, Intuitive Surgical, and IDEXX Laboratories were top contributors, driven by strong drug pipelines, innovation, and robust financial results. We exited UnitedHealth Group due to earnings misses, guidance cuts, and Medicare Advantage mispricing, despite its long-term potential to restore profitability. Thermo Fisher and argenx detracted from performance amid macro headwinds and lower-than-expected sales, but we retain conviction in their long-term prospects.

Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts

Zacks Investment Research

Wall Street's Insights Into Key Metrics Ahead of RadNet (RDNT) Q2 Earnings

Beyond analysts' top-and-bottom-line estimates for RadNet (RDNT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.

Wall Street's Insights Into Key Metrics Ahead of RadNet (RDNT) Q2 Earnings

RadNet, Inc. Announces Date of its Second Quarter 2025 Financial Results Conference Call

LOS ANGELES, July 25, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers and digital health solutions, announced today that it will host a conference call to discuss its second quarter 2025 financial results on Monday, August 11, 2025 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).

RadNet, Inc. Announces Date of its Second Quarter 2025 Financial Results Conference Call

Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group Add RadNet's AI-Powered Enhanced Breast Cancer Detection (EBCD) Program to its Membership Benefits in Southern California

LOS ANGELES, July 09, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services, today announced that Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group, affiliates of Heritage Provider Network (HPN), one of the largest physician-owned medical groups in Southern California, have agreed to reimburse RadNet for its EBCD program -- which will now be included as a benefit in their members' health plans.

Regal Medical Group, Lakeside Community Healthcare and ADOC Medical Group Add RadNet's AI-Powered Enhanced Breast Cancer Detection (EBCD) Program to its Membership Benefits in Southern California

See News Rankings

Charts implemented using Lightweight Charts™